Anti-EGFL7 Antibody (Parsatuzumab)
Catalog No.
F2083
Anti-EGFL7 Antibody (Parsatuzumab)
Featured Products
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody that binds to EGFL7 as an immunomodulator. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting angiogenesis and reducing vascular endothelial growth factor (VEGF) inhibition.
148.22 kDa
Dry ice
1312797-14-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RG7414, MEGF0444A
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9UHF1
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
EGFL7
Please avoid freeze-thaw cycles.